Pharma Grade Calcium Sulphate Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Pharma Grade Calcium Sulphate Market Expansion From $1.04 Billion In 2026 To $1.44 Billion In 2030
The market for pharma-grade calcium sulphate has seen notable expansion over the past few years. Its valuation is projected to rise from $0.96 billion in 2025 to $1.04 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This historic growth is driven by factors such as the expansion of pharmaceutical manufacturing, a higher demand for solid dosage formats, increased production of generic medications, greater utilization of calcium-based excipients, and a regulatory focus on excipient quality standards.
During the upcoming years, the market for pharmaceutical-grade calcium sulphate is anticipated to experience considerable expansion. By 2030, its value is projected to reach $1.44 billion, reflecting a compound annual growth rate (CAGR) of 8.4%. This forecasted growth is driven by factors such as rising global drug production, a greater reliance on high-performance excipients, an increasing need for consistent formulation quality, the expansion of nutraceutical manufacturing, and ongoing improvements in excipient processing. Key trends shaping this period include a heightened demand for high-purity pharmaceutical excipients, more widespread application in tablet and capsule formulations, greater adoption in calcium supplement production, an increase in quality-controlled excipient manufacturing, and a stronger emphasis on materials that comply with regulatory standards.
Download A Free Sample Report For Comprehensive Market Insights:
Pharma Grade Calcium Sulphate Market Demand Drivers Creating New Revenue Opportunities
The expanding demand for pharmaceutical products is set to drive the pharma grade calcium sulphate market forward. Pharmaceuticals encompass drugs and medications created, manufactured, and applied to diagnose, treat, or prevent illnesses in humans and animals. This rising demand largely stems from the increasing prevalence of chronic diseases, which require more individuals to rely on long-term treatments for managing conditions like diabetes, cardiovascular ailments, and cancer. By acting as a high-purity excipient, pharma grade calcium sulphate improves drug formulations by ensuring consistent tablet hardness, stability, and controlled release of active ingredients. For example, in April 2024, Eurostat, an official statistical agency of the European Union based in Luxembourg, reported that EU imports of medicinal and pharmaceutical products grew by 6.1% in 2023, reaching $137.4 billion (€119 billion) compared to the prior year. Over the same timeframe, EU exports totaled $319.2 billion (€277 billion), creating a trade surplus of $182.0 billion (€158 billion). Consequently, the increasing demand for pharmaceuticals is fueling growth in the pharma grade calcium sulphate market.
Pharma Grade Calcium Sulphate Market Segment Breakdown: Which Categories Generate The Most Revenue?
The pharma grade calcium sulphate market covered in this report is segmented –
1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite
2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents
3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution
Subsegments:
1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade
2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate
3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite
Pharma Grade Calcium Sulphate Market Trends Driving Strategic Industry Expansion
Key industry players in the pharma-grade calcium sulphate market are concentrating on developing novel products through the use of synthetic medical-grade bassanite, aimed at improving both the purity and consistency of calcium sulphate offerings. This synthetic medical-grade bassanite, a high-purity, partially dehydrated form of calcium sulphate (CaSO₄·0.5H₂O), facilitates the production of pharma-grade calcium sulphate by supplying a consistent, contaminant-free source that adheres to stringent regulatory criteria for medical and pharmaceutical applications. For example, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, a medical institute headquartered in India, introduced Caspro and Bonyx, two innovative drug-eluting bone graft products crafted from synthetic medical-grade bassanite to guarantee high purity, biocompatibility, and controlled drug delivery in advanced orthopedic settings. Caspro is a self-setting, moldable bone cement derived from calcium sulfate hemihydrate strengthened with phosphate ions, making it suitable for filling bone defects and enabling drug delivery directly at the implantation site for over 21 days. Bonyx comprises osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, allowing for sustained drug release exceeding 30 days. These offerings mark a considerable advancement in localized therapy for bone infections and regeneration, showcasing how pharma-grade calcium sulfate can be applied in next-generation biomedical solutions that comply with rigorous global standards.
Pharma Grade Calcium Sulphate Market Key Players And Strategic Industry Positioning
Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères
Access The Complete Pharma Grade Calcium Sulphate Market Report:
Pharma Grade Calcium Sulphate Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
